help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whorwood, C. B.
Right arrow Articles by Stewart, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whorwood, C. B.
Right arrow Articles by Stewart, P. M.

Endocrinology, Vol 132, 2287-2292, Copyright © 1993 by Endocrine Society


ARTICLES

Licorice inhibits 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid levels and potentiates glucocorticoid hormone action

CB Whorwood, MC Sheppard and PM Stewart
Department of Medicine, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, United Kingdom.

11 beta-Hydroxysteroid dehydrogenase (11 beta HSD) is responsible for the interconversion of cortisol to cortisone [corticosterone (B) to 11- dehydrocorticosterone in rodents] and confers ligand specificity to the mineralocorticoid receptor. Inhibition of 11 beta HSD by licorice derivatives [glycyrrhizic and glycyrrhetinic (GE) acids] results in cortisol/B and not aldosterone acting as a potent mineralocorticoid. 11 beta HSD is ubiquitously expressed and, by converting active glucocorticoid to inactive metabolites, may be an important prereceptor regulator of ligand access to the glucocorticoid receptor (GR). To investigate this further, we have studied the effect of 11 beta HSD inhibition by licorice derivatives on PRL gene expression (a known glucocorticoid target gene) in rat pituitary GH3 cells. Glycyrrhizic acid administration to rats in vivo (75 mg/kg.day for 5 days) resulted in inhibition of 11 beta HSD activity, as previously reported, but also a significant reduction in steady state 11 beta HSD mRNA levels in both predominantly mineralocorticoid (kidney and distal colon) and glucocorticoid (liver and pituitary) target tissues. In vitro, 11 beta HSD mRNA and activity were present in rat pituitary GH3 cells (81% conversion of B to 11-dehydrocorticosterone/4 x 10(6) cells after 24-h incubation) and inhibited by GE in a dose-dependent fashion. While B or GE alone (10(-8)-10(-5) M) had little or no effect on PRL mRNA levels or immunoassayable PRL, combinations of GE plus B resulted in marked inhibition of PRL mRNA levels and secretion, to such an extent that a concentration of 10(-6) M B with 10(-6) M GE was more potent than equimolar concentration of the synthetic GR agonist RU 28362. This inhibitory effect on PRL mRNA levels was blocked by a 10-fold excess of the GR antagonist RU 38486, but not by a 10-fold excess of the mineralocorticoid receptor antagonist RU 26752, confirming that this potentiation of glucocorticoid hormone action was operating through the GR and not the mineralocorticoid receptor. In addition to its established role as a competitive inhibitor of 11 beta HSD, licorice results in pretranslational inhibition of 11 beta HSD both in vitro and in vivo. 11 beta HSD is clearly an important mechanism in regulating tissue levels of active glucocorticoid and, hence, ligand supply to the GR.


This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
S. Chintharlapalli, S. Papineni, I. Jutooru, A. McAlees, and S. Safe
Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor {gamma} agonists in colon cancer cells
Mol. Cancer Ther., May 1, 2007; 6(5): 1588 - 1598.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. W. Tomlinson, M. Sherlock, B. Hughes, S. V. Hughes, F. Kilvington, W. Bartlett, R. Courtney, P. Rejto, W. Carley, and P. M. Stewart
Inhibition of 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Activity in Vivo Limits Glucocorticoid Exposure to Human Adipose Tissue and Decreases Lipolysis
J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 857 - 864.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. W. Tomlinson, E. A. Walker, I. J. Bujalska, N. Draper, G. G. Lavery, M. S. Cooper, M. Hewison, and P. M. Stewart
11{beta}-Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response
Endocr. Rev., October 1, 2004; 25(5): 831 - 866.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. P. Gomez-Sanchez, V. Ganjam, Y. J. Chen, Y. Liu, M. Y. Zhou, C. Toroslu, D. G. Romero, M. D. Hughson, A. de Rodriguez, and C. E. Gomez-Sanchez
Regulation of 11{beta}-hydroxysteroid dehydrogenase enzymes in the rat kidney by estradiol
Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E272 - E279.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. A. Fenton, C.-L. Chou, S. Ageloff, W. Brandt, J. B. Stokes, and M. A. Knepper
Increased collecting duct urea transporter expression in Dahl salt-sensitive rats
Am J Physiol Renal Physiol, July 1, 2003; 285(1): F143 - F151.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. Suzuki, K. Koyama, A. Darnel, H. Ishibashi, S. Kobayashi, H. Kubo, T. Suzuki, H. Sasano, and Z. S. Krozowski
Dexamethasone Upregulates 11{beta}-Hydroxysteroid Dehydrogenase Type 2 in BEAS-2B Cells
Am. J. Respir. Crit. Care Med., May 1, 2003; 167(9): 1244 - 1249.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. Ferrari, M. G. Bianchetti, A. Sansonnens, and F. J. Frey
Modulation of Renal Calcium Handling by 11{beta}-Hydroxysteroid Dehydrogenase Type 2
J. Am. Soc. Nephrol., October 1, 2002; 13(10): 2540 - 2546.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. J. Bujalska, E. A. Walker, M. Hewison, and P. M. Stewart
A Switch in Dehydrogenase to Reductase Activity of 11{beta}-Hydroxysteroid Dehydrogenase Type 1 upon Differentiation of Human Omental Adipose Stromal Cells
J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1205 - 1210.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Ferrari, A. Sansonnens, B. Dick, and F. J. Frey
In Vivo 11{beta}-HSD-2 Activity: Variability, Salt-Sensitivity, and Effect of Licorice
Hypertension, December 1, 2001; 38(6): 1330 - 1336.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Bertram, A. R. Trowern, N. Copin, A. A. Jackson, and C. B. Whorwood
The Maternal Diet during Pregnancy Programs Altered Expression of the Glucocorticoid Receptor and Type 2 11{beta}-Hydroxysteroid Dehydrogenase: Potential Molecular Mechanisms Underlying the Programming of Hypertension in Utero
Endocrinology, July 1, 2001; 142(7): 2841 - 2853.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Korbonits, I. Bujalska, M. Shimojo, J. Nobes, S. Jordan, A. B. Grossman, and P. M. Stewart
Expression of 11{beta}-Hydroxysteroid Dehydrogenase Isoenzymes in the Human Pituitary: Induction of the Type 2 Enzyme in Corticotropinomas and Other Pituitary Tumors
J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2728 - 2733.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. B. Feinstein and R. P. Schleimer
Regulation of the Action of Hydrocortisone in Airway Epithelial Cells by 11beta -Hydroxysteroid Dehydrogenase
Am. J. Respir. Cell Mol. Biol., September 1, 1999; 21(3): 403 - 408.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
K. E. Sheppard, K. X. Z. Li, and D. J. Autelitano
Corticosteroid receptors and 11beta -hydroxysteroid dehydrogenase isoforms in rat intestinal epithelia
Am J Physiol Gastrointest Liver Physiol, September 1, 1999; 277(3): G541 - G547.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
I. J. Bujalska, S. Kumar, M. Hewison, and P. M. Stewart
Differentiation of Adipose Stromal Cells: The Roles of Glucocorticoids and 11{beta}-Hydroxysteroid Dehydrogenase
Endocrinology, July 1, 1999; 140(7): 3188 - 3196.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
P. M. Stewart, A. Boulton, S. Kumar, P. M. S. Clark, and C. H. L. Shackleton
Cortisol Metabolism in Human Obesity: Impaired Cortisone->Cortisol Conversion in Subjects with Central Adiposity
J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 1022 - 1027.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Condon, C. Gosden, D. Gardener, P. Nickson, M. Hewison, A. J. Howie, and P. M. Stewart
Expression of Type 2 11{beta}-Hydroxysteroid Dehydrogenase and Corticosteroid Hormone Receptors in Early Human Fetal Life
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4490 - 4497.
[Abstract] [Full Text]


Home page
FASEB J.Home page
G. Mazzocchi, G. P. Rossi, G. Neri, L. K. Malendowicz, G. Albertin, and G. G. Nussdorfer
11ß-Hydroxysteroid dehydrogenase expression and activity in the human adrenal cortex
FASEB J, November 1, 1998; 12(14): 1533 - 1539.
[Abstract] [Full Text]


Home page
Arch DermatolHome page
D. J. Brown and A. M. Dattner
Phytotherapeutic Approaches to Common Dermatologic Conditions
Arch Dermatol, November 1, 1998; 134(11): 1401 - 1404.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. L. Ricketts, J. M. Verhaeg, I. Bujalska, A. J. Howie, W. E. Rainey, and P. M. Stewart
Immunohistochemical Localization of Type 1 11{beta}-Hydroxysteroid Dehydrogenase in Human Tissues
J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1325 - 1335.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Hanafusa, T. Mune, T. Tanahashi, Y. Isomura, T. Suwa, M. Isaji, H. Daido, H. Morita, M. Murayama, and K. Yasuda
Altered corticosteroid metabolism differentially affects pituitary corticotropin response
Am J Physiol Endocrinol Metab, February 1, 2002; 282(2): E466 - E473.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society